Indeterminate Colitis clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the long-term safety and clinical status of pediatric patients with Inflammatory Bowel Disease (IBD). Particular attention will be directed to recording safety outcomes reported in association with infliximab and other prescribed IBD therapies. In addition, information on disease status and quality of life will be collected.
San Francisco, California and other locations
Our lead scientists for Indeterminate Colitis research studies include Mel Heyman.
Last updated: